Amplia Therapeutics (ASX:ATX) Debt-to-Revenue : N/A (As of Sep. 2023)

Amplia Therapeutics Debt-to-Revenue Chart

Amplia Therapeutics Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Debt-to-Revenue		Get a 7-Day Free Trial					N/A	N/A	N/A	N/A	N/A

Amplia Therapeutics Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial															N/A	N/A	N/A	N/A	N/A

Competitive Comparison of Amplia Therapeutics's Debt-to-Revenue

For the Biotechnology subindustry, Amplia Therapeutics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amplia Therapeutics's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amplia Therapeutics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Amplia Therapeutics's Debt-to-Revenue falls into.

Amplia Therapeutics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Amplia Therapeutics's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Amplia Therapeutics's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Sep. 2023) Revenue data.

Amplia Therapeutics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplia Therapeutics (ASX:ATX) Business Description